Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 1065

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 11
Chunk 1065
---
 the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.

/s/
Marcum LLP

Marcum
LLP

We
have served as the Company’s auditor since 2022.

Morristown, NJ

March 28, 2025

F-2

CONDUIT
PHARMACEUTICALS INC.

CONSOLIDATED
BALANCE SHEETS 

(in
thousands, except share amounts)

    December 31,
2024  
    December 31,
2023 
  
    ASSETS 

    Current assets 

    Cash and cash equivalents 
    $554  
    $4,228 
  
    Prepaid expenses 
     2,161  
     1,505 
  
    Total current assets 
     2,715  
     5,733 
  
    Operating lease right-of-use assets. net 
     263  
     - 
  
    Property, plant and equipment, net 
     40  
     - 
  
    Prepaid expenses and other long-term assets 
     1,175  
     1,491 
  
    Total assets 
    $4,193  
    $7,224 
  
    LIABILITIES AND STOCKHOLDERS’ DEFICIT 

    Current liabilities 

    Accounts payable 
    $1,428  
    $215 
  
    Accrued expenses and other current liabilities 
     1,963  
     601 
  
    Operating lease liability, current portion 
     119  
     - 
  
    Convertible promissory note payable 
     800  
     800 
  
    Convertible promissory notes payable at fair value 
     2,985  
     - 
  
    Convertible promissory notes payable at fair value – related parties 
     2,871  
     - 
  
    Convertible promissory notes payable at fair value 
     2,871  
     - 

    Notes payable 
     150  
     185 
  
    Notes payable – related parties 
     425  
     - 
  
    Notes payable 
     425  
     - 

    Total current liabilities 
     10,741  
     1,801 
  
    Operating lease liability, non-current portion 
     107  
     -